A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants
N/A
The purpose of this observational study of metastatic castration-resistant ...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-03
Trial ID
NCT02813408
Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)
N/A
This is a Long Term Follow Up study to eRADicAte, an open label study desig...
Status
Unknown
Location
Chesapeake urology Research Associates
Start Date
2017-10-01
Trial ID
NCT03414437
A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol
N/A
The primary purpose of this study is to evaluate the influence of HSD3B1 (1...
Status
Completed
Location
Sociedade Beneficiante de Senhoras - Hospital Sirio Libanes
A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
PHASE1
The purpose of this study is to evaluate the effects of abiraterone on the ...
Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide
PHASE2
Primary Objective:
To demonstrate the superiority in term of radiographic ...